Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
329.00    0.00 (0.00%)
Bid:
322.00
Ask:
336.00
Spread: 14.00 (4.348%)
Market Cap: £41.75m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

15 Jul 2016 07:00

RNS Number : 2623E
BrainJuicer Group PLC
15 July 2016
 

 

 

 

Press Release

15 July 2016

 

 

BrainJuicer Group PLC (AIM: BJU)

("BrainJuicer", or "the Company")

 

Six month Trading Update

 

BrainJuicer, the innovative international market research agency, today releases the following six month ("H1") trading update. The Company will announce its interim results for the six months to 30 June 2016 on 16 September 2016.

 

Top line growth during H1 was generally encouraging. Revenue increased by 13%, and by 9% in constant currencies, and gross profit (our main top-line performance indicator) grew by 15%, and 11% in constant currencies. Our largest market, the US, performed strongly, with gross profit rising by some 27%; gross profit in Continental Europe and Brazil also grew well, increasing by 30% and 22% respectively. Gross profit in our second largest market, the UK, declined by 2%, and in our China and Singapore region it also declined slightly by 5%.

 

Our Ad Testing and Brand Tracking services continued to grow strongly, with gross profit up 59% year on year. Much of this business is Ongoing in nature (as opposed to Ad Hoc), and builds on the "Fame, Feeling & Fluency" approach to brand building that we introduced last year.

 

After factoring in our new creative agency, System1, which was launched during H1 and, as anticipated, incurred costs of some £0.3m, BrainJuicer's operating profit increased by some 41% to around £1.7m. After adjusting for exceptional items (share based payments and also the one-off costs in H1 2015 relating to due diligence work and our Head Office move) normalized H1 pre-tax profit will be similar to the £1.7m reported in 2015.

 

BrainJuicer's financial position remains strong. At the end of June the Company had a cash balance of £5.2m (December 2015: £6.4m), after returning £2.2m to shareholders during H1 by way of dividends and share buy-backs.

The Company generates the majority of its annual profit in the second half of the year, and whilst our revenue visibility is, as ever, limited the Board believes that the Company is in a position to meet market expectations for the full year.

 

The decline in the value of sterling versus the US Dollar, the Euro and other leading currencies following the referendum on the UK's membership of the EU benefits the Company's non-UK profits reported in sterling. The results of our overseas businesses are translated into sterling using monthly average exchange rates. Beyond this, it is too early to say what the impact of the UK's exit from the EU on the market research budgets of our clients is likely to be.

 

This announcement contains inside information. The Company can be found at www.brainjuicer.com.

 

For further information, please contact:

BrainJuicer Group PLC

Tel: +44 (0)20 7043 1000

 

John Kearon, Chief Executive Officer

 

James Geddes, Chief Financial Officer

 

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Henry Fitzgerald-O'Connor / Emma Gabriel

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSABRNWABAAR
Date   Source Headline
11th Apr 20121:46 pmRNSAnnual Report and Accounts
22nd Mar 20127:00 amRNSResults for 12 Months ended 31 Dec 2011
20th Jan 20125:39 pmRNSTransaction in Own Shares
19th Jan 20127:00 amRNSTrading Update
16th Jan 20127:47 amRNSTransaction in Own Shares
10th Jan 20122:31 pmRNSTransaction in Own Shares
5th Jan 20121:24 pmRNSDirectorate Change
2nd Dec 20117:00 amRNSTransaction in Own Shares
22nd Nov 20119:35 amRNSTransaction in Own Shares
3rd Nov 20113:23 pmRNSTransaction in Own Shares
2nd Nov 20115:39 pmRNSTransaction in Own Shares
1st Nov 20115:47 pmRNSTransaction in Own Shares
31st Oct 20114:14 pmRNSTransaction in Own Shares
29th Sep 20115:09 pmRNSDirector/PDMR Shareholding
12th Sep 20118:29 amRNSBlocklisting Interim Review
30th Aug 20119:52 amRNSTotal Voting Rights
13th Jul 20117:00 amRNSTrading Update
28th Jun 20113:19 pmRNSTransaction in Own Shares
27th Jun 201110:37 amRNSDirector Dealing
20th Jun 20116:21 pmRNSTransaction in Own Shares
17th Jun 20114:39 pmRNSTransaction in Own Shares
7th Jun 20117:00 amRNSDirector Dealing
24th May 20114:32 pmRNSResult of AGM
12th May 201111:24 amRNSHolding(s) in Company
5th May 201112:36 pmRNSHolding(s) in Company
4th May 20114:34 pmRNSDirector Dealing
7th Apr 20115:57 pmRNSTransaction in Own Shares
4th Apr 20117:39 amRNSTransaction in Own Shares
24th Mar 20117:00 amRNSFinal Results
10th Mar 20119:24 amRNSBlocklisting Interim Review
21st Jan 20114:52 pmRNSHolding(s) in Company
14th Jan 20118:02 amRNSTrading Update
11th Jan 20116:10 pmRNSTransaction in Own Shares
26th Nov 20107:00 amRNSAppointment of Director
3rd Nov 20105:24 pmRNSHolding(s) in Company
22nd Oct 20108:33 amRNSHolding(s) in Company
22nd Oct 20108:33 amRNSHolding(s) in Company
12th Oct 20106:17 pmRNSTransaction in Own Shares
1st Oct 201012:23 pmRNSSubstantial Shareholder and Director Dealing
29th Sep 20105:48 pmRNSTransaction in Own Shares
22nd Sep 20107:00 amRNSInterim Results
10th Sep 20107:00 amRNSBlocklisting Interim Review
21st Jul 20101:22 pmRNSDirector Dealings
14th Jul 20108:14 amRNSTrading Update
28th May 201012:37 pmRNSTotal Voting Rights
18th May 20104:01 pmRNSTrading Update & Name change of Nomad and Broker
4th May 20105:52 pmRNSBlocklisting Application
22nd Apr 201012:17 pmRNSResults of Buyback Program and Director Dealing
22nd Apr 20107:00 amRNSBuyback Programme
31st Mar 201010:26 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.